Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Idursulfase - Related Studies

Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Idursulfase

This study has been completed.

Study NCT00630747. Last updated on March 6, 2008. Information provided by Shire Human Genetic Therapies, Inc.

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Hunter Syndrome
		Mucopolysaccharidosis II

2	Additional conditions recognized in this trial
		Mucopolysaccharidoses
		Syndrome

3	More general conditions related to this trial
		Carbohydrate Metabolism, Inborn Errors
		Connective Tissue Diseases
		Disease
		Genetic Diseases, Inborn
		Genetic Diseases, X-Linked
		Heredodegenerative Disorders, Nervous System
		Lysosomal Storage Diseases
		Mental Retardation
		Mental Retardation, X-Linked
		Metabolic Diseases
		Metabolism, Inborn Errors
		Mucinoses
		Nervous System Diseases
		Neurobehavioral Manifestations
		Neurologic Manifestations
		Pathologic Processes

4	Interventions listed in this trial
		Idursulfase

5	Sponsors listed in this trial
		Shire Human Genetic Therapies, Inc.